(Bellesi et al., 2020), using flow cytometry, discovered that COVID-19 patients had greater levels of CD95 than controls, and that increased CD95 expression in CD4+ cells was related with decreased CD4+ counts, revealing a further mechanism for lymphopenia by which CD95 triggered apoptosis in COVID-19 patients. Here, FAS is linked to COVID-19.